Q BioMed Inc.

QBIO · OTC
Analyze with AI
2/28/2023
11/30/2022
8/31/2022
5/31/2022
Operating Activities
Net Income-$722$2,302-$795-$1,271
Dep. & Amort.$13$13$13$13
Deferred Tax-$308$0$0$0
Stock-Based Comp.$16$64$159$529
Change in WC$359$288$433$362
Other Non-Cash$504$1-$48$139
Operating Cash Flow-$138$2,668-$239-$110
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$3,143$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$3$0$0
Investing Cash Flow$0-$3,143$0$0
Financing Activities
Debt Repay.$111$303$350$0
Stock Issued$382-$100$0$125
Stock Repurch.-$111$0$0$0
Dividends Paid-$105-$460$0-$508
Other Fin. Act.$105$85$0$0
Financing Cash Flow$111$388$350$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$294-$88$111-$110
Supplemental Information
Beg. Cash$344$138$27$137
End Cash$50$50$138$27
Free Cash Flow-$138$2,668-$239-$110